Anne-Marie Heegaard

Anne-Marie Heegaard

cand.med., ph.d.

1991 …2019

Research activity per year

Network

Jean-Marie Delaissé

  • Klinisk Cellebiologisk Afdeling
  • University of Southern Denmark

External person

Ming Ding

  • University of Southern Denmark

External person

L W Fisher

  • University of California at San Francisco

External person

Magnus S. Ågren

  • University of Copenhagen

External person

Niels Foged

  • Det Teknisk-Naturvidenskabelige Fakultet, Aalborg Universitet

External person

Claus Holst-Hansen

  • Kardiologisk Afdeling, Aalborg Sygehus

External person

Camilla Appel

  • Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences

External person

Jean-Marie Delaissé

  • Nordi Bioscience A/S

External person

T Kilts

  • National Institutes of Health

External person

Kim Steen Henriksen

  • Programmering, logik og intelligente systemer

External person

M A Karsdal

  • Nordic Bioscience AS

External person

Lars Rolighed

  • Aarhus University

External person

L Ameye

  • Nestlé Research Center

External person

Gordon Munro

  • NeuroSearch
  • H. Lundbeck A/S

External person

Ming Ding

  • University of Southern Denmark

External person

Paolo Bianco

  • University La Sapienza
  • National Institutes of Health

External person

Marian F. Young

  • National Institutes of Health

External person

Christine Bruun Schiødt

  • Nordic Bioscience A/S

External person

Juha Risteli

  • University of Oulu

External person

Ming Ding

  • Ortopædkirurgi

External person

Laura Masi

  • University of Florence

External person

Pamela Gehron Robey

  • National Institutes of Health

External person

Gabri van der Pluijm

  • National Institutes of Health

External person

Martin Rehn

  • Lund University

External person

Signe Nedergaard

  • University of Copenhagen

External person

Lennart E. Franzén

  • Aleris Medilab

External person

Niklas R Jorgensen

  • University of Copenhagen

External person

Anja Olsen

  • Institute of Cancer Epidemiology, Danish Cancer Society

External person

Maria Uldall

  • Institut for Lægemiddeldesign og Farmakologi

External person

A. D. Berendsen

  • National Institutes of Health

External person

Per Aspenberg

  • Linköping University

External person

Majbritt Larsen

  • Institut for Lægemiddeldesign og Farmakologi

External person

Christina Sveigaard

  • H. Lundbeck A/S

External person

Maria Luisa Brandi

  • University of Florence

External person

Henrik Løvendahl Jørgensen

  • University of Copenhagen

External person

Claus Christiansen

  • Center for Clinical and Basic Research (CCBR), Ballerup

External person

Klaus Dinkel

  • Affectis Pharmaceuticals AG

External person

Susanne Syberg

  • University of Copenhagen

External person

Sebastiano Mercadante

  • University of Palermo

External person

Stanko S Stojilkovic

  • National Institutes of Health

External person

J. Christensen

  • Danish Cancer Society

External person

Yury D Bogdanov

  • Molecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, Gower Street, London WC1E 6BT, UK.

External person

Tobias Bjørn Sørensen

  • Institut for Sprog og Kultur, AAU

External person

H.J.T. Coelingh Bennink

  • Partarhei Bioscience, Zeist

External person

John N Wood

  • Molecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, Gower Street, London WC1E 6BT, UK. Electronic address: [email protected].
  • University College London

External person

M Ono

  • National Institutes of Health

External person

Janet M. Kerr

  • National Institutes of Health

External person

Wojciech Grzesik

  • National Institutes of Health

External person

H.J.T. Coelingh Bennink

  • Pantarhei Bioscience, Zeist

External person

Brian Lee Schmidt

  • New York University

External person

Vikas Surve

  • Nordic Bioscience A/S

External person

Anke Unger

  • Lead Discovery Center GmbH

External person

Henrik L. Jorgensen

  • University of Copenhagen

External person

Kirsten Frederiksen

  • Danish Cancer Society
  • Kræftens Bekæmpelse

External person

F Syed-Picard

  • National Institutes of Health
  • University College London

External person

Michael F Jarvis

  • Abbott Laboratories

External person

Nicole Newell Scheff

  • New York University

External person

Anna Thit Johnsen

  • University of Copenhagen

External person

P. Schwarz

  • University of Copenhagen

External person

A. Oldberg

  • University of Lund

External person

Morten A Karsdal

  • Nordic Bioscience A/S
  • Nordic Bioscience AS

External person

Maria Uldall

  • Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences

External person

Thomas Martin

  • Institut for Samfund og Globalisering

External person

Mohammed A Nassar

  • Molecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, Gower Street, London WC1E 6BT, UK.

External person

Ulrich K. Vetter

  • National Institutes of Health

External person

Frank H Ebetino

  • P&G Pharmaceuticals

External person

Laura Mezzanotte

  • Leiden University Medical Center

External person

Chi Tonglien Viet

  • New York University

External person

Toyoko Sato

  • Institut for Interkulturel Kommunikation og Ledelse

External person

C. K. Appel

  • Kobenhavns Universitet

External person

Tine Troen

  • Forskningscenter Risø

External person

Karina L. Nielsen

  • Nordic Bioscience A/S

External person

Bo Lind

  • Copenhagen General Practitioners' Laboratory

External person

C. Christiansen

  • Nordic Bioscience, Herlev

External person

Jeppe Gram

  • Medicinsk Område

External person

Troels S. Jensen

  • Aarhus University Hospital /Aarhus Universitetshospital

External person

Anette T. Møller

  • Aarhus University Hospital /Aarhus Universitetshospital

External person

Justyna M. C. Bahl

  • Statens Serum Institut

External person

Louise S. Dalbøge

  • Institut for Lægemiddeldesign og Farmakoloig
  • Novo Nordisk Foundation

External person

Y. Bi

  • National Institutes of Health

External person

Lisbeth Birk Møller

  • Institut for Natur, Systemer og Modeller

External person

Alexander Friedenstein

  • National Institutes of Health

External person

Sonia Santana-Varela

  • Molecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, Gower Street, London WC1E 6BT, UK.

External person

C.F Holinka

  • PharmConsult, New York

External person

Theresa E. Hefferan

  • National Institutes of Health

External person

Louise Hansen

  • Danish Cancer Society

External person

Jean-Marie Delaissé

  • University of Southern Denmark
  • Aarhus University

External person

Kyomi Ibaraki

  • National Institutes of Health

External person

Morten Karsdal

  • Nordic Bioscience
  • Nordic Bioscience AS

External person

Michael S Minett

  • Molecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, Gower Street, London WC1E 6BT, UK.

External person

Andreas Hald

  • University of Copenhagen

External person

Ming Ding

  • University of Southern Denmark

External person

Orla Gallagher

  • University of Sheffield

External person

B. Lind

  • Copenhagen General Practitioners' Laboratory

External person

Pentti Tengvall

  • Linköping University

External person

Jens Bollerslev

  • Forskningsområdet, Sundhedsvidenskab
  • University of Oslo

External person

Neal S. Fedarko

  • National Institutes of Health

External person

Björn Pasternak

  • Linköping University
  • Statens Serum Institut
  • Karolinska Institutet

External person

M. Visser

  • Pantarhei Bioscience, Zeist

External person

J. Christensen

  • Danish Cancer Society

External person

Keith P. Mintz

  • National Institutes of Health

External person

L.N. Jorgensen

  • University of Copenhagen

External person

P. Kenemans

  • VU University Medical Center

External person

Fie Juhl Vojdeman

  • University of Copenhagen

External person

Peter I Croucher

  • University of Sheffield

External person

C.F. Holinka

  • PharmConsult

External person

Thomas L. Andersen

  • University of Copenhagen

External person

Nils Brünner

  • Institute of Veterinary Pathobiology, Royal Veterinary and Agricultural University, Frederiksberg

External person

Lisbeth B. Møller

  • Copenhagen University Hospital

External person

Mara Riminucci

  • Universitá dell`Aquila

External person

Alessandro Corsi

  • Universitá La Sapienza, Rome

External person

M F Young

  • National Institutes of Health

External person

Pernille H Ohlsson

  • University of Copenhagen

External person

Erik Dupont

  • Aarhus University Hospital /Aarhus Universitetshospital

External person